Equities
Health CareHealth Care Equipment & Services
  • Price (USD)142.03
  • Today's Change2.90 / 2.08%
  • Shares traded317.52k
  • 1 Year change+68.62%
  • Beta1.5592
Data delayed at least 15 minutes, as of Oct 15 2021 21:10 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

CONMED Corporation is a medical technology company that is engaged in the development, manufacturing, and sale on a global basis of surgical devices and related equipment. The Company's products consist of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine instrumentation and small bone, large bone, and specialty powered surgical instruments as well as imaging systems for use in minimally invasive surgery procedures including dissociated two horizontal deviation and three horizontal deviation vision technologies. General surgery consists of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, a line of cardiac monitoring products as well as electrosurgical generators and related instruments. Its products are used by surgeons and physicians in a variety of specialties, including orthopedics, general surgery, gynecology, neurosurgery, thoracic surgery, and gastroenterology.

  • Revenue in USD (TTM)978.50m
  • Net income in USD54.14m
  • Incorporated--
  • Employees3.40k
  • Location
    Conmed Corp11311 Concept BoulevardLARGO 33773United StatesUSA
  • Phone+1 (727) 214-2974
  • Fax+1 (302) 655-5049
  • Websitehttps://www.conmed.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Axonics Inc150.27m-68.17m2.91bn416.00--5.77--19.39-1.68-1.683.7510.940.32871.147.56361,221.20-14.91---15.87--61.94---45.36--10.73-7.310.0002--707.06--31.30------
NuVasive, Inc.1.15bn1.85m2.92bn2.70k1,634.583.4719.932.530.03460.034622.3116.280.48081.015.78427,098.500.07731.550.09731.8172.3172.620.16072.572.301.820.51210.00-10.065.31-156.95--0.3312--
Integer Holdings Corp1.11bn96.72m2.95bn7.50k30.612.2416.612.662.922.9233.3939.840.45365.015.30147,652.103.962.294.242.4727.4929.448.735.191.753.730.33720.00-14.686.05-15.30--2.89--
Patterson Companies, Inc.6.28bn165.57m3.13bn7.80k18.873.1912.810.4981.701.7064.5610.072.336.8716.84805,269.906.10-0.34759.84-0.49219.5421.732.62-0.19960.7877--0.3914--7.691.88126.51-3.43-20.132.93
Cytek Biosciences Inc-100.00bn-100.00bn3.22bn429.00--------------1.37------------------------6.76--0.00--60.39--119.11------
AtriCure Inc.243.13m-56.68m3.27bn750.00--8.50--13.47-1.29-1.295.538.390.3461.758.57324,177.30-8.07-8.44-8.72-9.3574.6072.67-23.31-17.002.94-11.740.1251---10.529.74-36.83---17.12--
Adapthealth Corp1.75bn-90.37m3.31bn8.70k--1.7499.531.89-1.97-1.9718.8214.530.643526.248.29200,718.00-4.61---5.47--20.40---7.16--0.84071.190.5004--102.15---657.38------
Haemonetics Corporation903.41m64.49m3.57bn2.71k55.595.2723.303.951.261.2617.6913.270.55991.566.59333,609.304.003.924.984.9146.2746.027.145.591.576.200.53670.00-11.94-0.8593.85---18.40--
Merit Medical Systems, Inc.1.03bn28.24m3.92bn5.99k139.003.9433.273.800.50060.500618.3117.650.61412.807.06172,185.201.681.361.901.5243.5643.602.742.171.2112.000.22760.00-3.1112.20-280.57---1.41--
Nevro Corp409.13m-68.27m4.07bn843.00--11.35--9.94-1.97-1.9711.8310.280.60491.386.71485,327.40-10.09-12.91-12.90-15.3270.0069.17-16.69-17.966.37-1.600.2901---7.2339.0719.89--3.77--
Conmed Corp978.50m54.14m4.14bn3.40k82.075.5632.824.231.731.7331.7925.530.56142.266.26287,794.403.111.603.451.7955.2954.665.532.751.172.400.49596.80-9.703.70-66.75-20.78-2.810.00
Inari Medical Inc208.18m25.02m4.30bn456.00192.1219.35157.6420.660.44840.44843.734.450.87121.388.88456,526.3010.47--11.49--92.15--12.02--6.65298.980.00--173.17--1,256.96------
LivaNova PLC1.02bn-379.12m4.46bn4.00k--3.95--4.37-7.79-7.8020.9721.240.41712.335.55255,431.00-15.47-4.59-19.29-5.5365.3064.85-37.09-11.050.9711-0.67770.3892---13.83---120.85------
Pacific Biosciences of California Inc105.83m-77.21m4.85bn412.00--18.79--45.86-0.4648-0.46480.53891.300.1453.496.77256,856.80-10.58-37.11-12.03-46.5342.7139.54-72.96-74.8625.78-22.210.7762---13.20-3.19134.95---19.16--
Premier Inc1.72bn260.84m4.86bn2.60k16.622.1811.422.822.382.3814.6418.200.53197.154.53661,981.609.4115.8011.5819.5448.6564.2017.7031.720.845315.070.17675.9932.448.16-56.39-20.442.91--
ICU Medical Inc1.28bn103.26m4.90bn7.90k48.423.1425.663.834.774.7759.0473.430.69842.608.03161,866.005.645.286.626.0736.7637.998.076.283.671,172.470.00190.000.378830.05-14.0214.0748.43--
Data as of Oct 15 2021. Currency figures normalised to Conmed Corp's reporting currency: US Dollar USD

Institutional shareholders

53.13%Per cent of shares held by top holders
HolderShares% Held
BlackRock Fund Advisorsas of 30 Jun 20214.29m14.70%
The Vanguard Group, Inc.as of 30 Jun 20213.07m10.51%
EARNEST Partners LLCas of 30 Jun 20211.63m5.59%
Champlain Investment Partners LLCas of 30 Jun 20211.48m5.06%
SSgA Funds Management, Inc.as of 30 Jun 20211.01m3.48%
Capital Research & Management Co. (Global Investors)as of 30 Jun 2021946.00k3.24%
Principal Global Investors LLCas of 30 Jun 2021853.15k2.93%
Macquarie Investment Management Business Trustas of 30 Jun 2021770.28k2.64%
Dimensional Fund Advisors LPas of 30 Jun 2021762.04k2.61%
Invesco Advisers, Inc.as of 30 Jun 2021692.15k2.37%
More ▼
Data from 30 Jun 2021 - 30 Jun 2021Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
image